ArticleBritish journal of clinical pharmacology2016

Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer.

Manon Launay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.